Nuclear Stocks To Follow Now – November 7th

Oklo, BWX Technologies, NuScale Power, Centrus Energy, X-Energy, Nano Nuclear Energy, and Karyopharm Therapeutics are the seven Nuclear stocks to watch today, according to MarketBeat’s stock screener tool. “Nuclear stocks” are shares of companies involved in nuclear power, such as uranium miners, reactor designers, nuclear plant operators, and fuel suppliers. Investors may buy them to gain exposure to nuclear energy’s role in electricity generation, but these stocks can be affected by regulation, project costs, uranium prices, and public attitudes toward nuclear power. These companies had the highest dollar trading volume of any Nuclear stocks within the last several days.

Oklo (OKLO)

Oklo Inc. designs and develops fission power plants to provide reliable and commercial-scale energy to customers in the United States. It also provides used nuclear fuel recycling services. The company was founded in 2013 and is based in Santa Clara, California.

OKLO traded up $4.35 during midday trading on Friday, hitting $23.55. 24,869,573 shares of the company traded hands, compared to its average volume of 9,472,418. The firm has a market capitalization of $4.38 billion, a PE ratio of -25.05 and a beta of 1.31. The company’s 50-day moving average is $33.56 and its 200 day moving average is $52.36. Oklo has a 52 week low of $18.53 and a 52 week high of $117.44.

BWX Technologies (BWXT)

BWX Technologies, Inc., together with its subsidiaries, manufactures and sells nuclear components in the United States, Canada, and internationally. It operates through two segments, Government Operations and Commercial Operations. The Government Operations segment designs and manufactures naval nuclear components, reactors, and nuclear fuel; fabrication activities; and supplies proprietary and sole-source valves, manifolds, and fittings to naval and commercial shipping customers.

Shares of BWXT stock traded up $4.51 during trading hours on Friday, reaching $119.47. The company had a trading volume of 2,145,632 shares, compared to its average volume of 1,118,615. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.33 and a current ratio of 2.40. The business has a fifty day moving average price of $140.58 and a 200-day moving average price of $182.63. BWX Technologies has a one year low of $112.54 and a one year high of $241.82. The firm has a market cap of $10.95 billion, a PE ratio of 29.28, a price-to-earnings-growth ratio of 1.84 and a beta of 0.75.

NuScale Power (SMR)

NuScale Power Corporation engages in the development and sale of modular light water reactor nuclear power plants to supply energy for electrical generation, district heating, desalination, hydrogen production, and other process heat applications. It offers NuScale Power Module (NPM), a water reactor that can generate 77 megawatts of electricity (MWe); and VOYGR power plant designs for three facility sizes that are capable of housing from one to four and six or twelve NPMs.

NuScale Power stock traded up $0.64 during midday trading on Friday, reaching $5.01. 40,698,565 shares of the company traded hands, compared to its average volume of 31,305,372. NuScale Power has a 12 month low of $4.28 and a 12 month high of $32.09. The business has a 50 day moving average of $7.44 and a two-hundred day moving average of $10.56. The firm has a market capitalization of $2.15 billion, a price-to-earnings ratio of -4.24 and a beta of 2.42.

Centrus Energy (LEU)

Centrus Energy Corp. supplies nuclear fuel components and services for the nuclear power industry in the United States, Belgium, Japan, and internationally. The company operates through two segments, Low-Enriched Uranium (LEU) and Technical Solutions. The LEU segment sells separative work units (SWU) components of LEU; natural uranium hexafluoride, uranium concentrates, and uranium conversion; and enriched uranium products to utilities that operate nuclear power plants.

NYSE:LEU traded up $15.53 during trading hours on Friday, reaching $104.56. The company had a trading volume of 1,319,378 shares, compared to its average volume of 941,776. The firm has a market cap of $2.09 billion, a price-to-earnings ratio of 30.57, a PEG ratio of 9.09 and a beta of 1.40. The company has a current ratio of 5.39, a quick ratio of 4.52 and a debt-to-equity ratio of 1.39. The firm’s 50 day moving average price is $136.02 and its 200-day moving average price is $181.07. Centrus Energy has a 52 week low of $84.86 and a 52 week high of $345.60.

X-Energy (XE)

X-energy is a leading designer of advanced nuclear reactor technology (commonly referred to as small modular reactors, “SMRs”) and manufacturer of advanced nuclear fuels. We believe these scalable, power generation technologies help satisfy historically unprecedented electricity demand growth, driven by the development of AI and associated data center infrastructure.

Shares of XE stock traded up $1.43 on Friday, reaching $10.43. The stock had a trading volume of 6,977,314 shares, compared to its average volume of 6,476,932. X-Energy has a 1 year low of $8.68 and a 1 year high of $37.10. The firm has a market cap of $4.24 billion and a PE ratio of -69.53. The stock’s 50 day simple moving average is $13.90.

Nano Nuclear Energy (NNE)

Nano Nuclear Energy stock traded up $1.47 during mid-day trading on Friday, reaching $11.11. 2,823,597 shares of the stock traded hands, compared to its average volume of 1,987,870. Nano Nuclear Energy has a 12-month low of $9.29 and a 12-month high of $41.50. The business’s 50-day moving average is $14.96 and its 200-day moving average is $21.23. The stock has a market capitalization of $596.61 million, a PE ratio of -16.10 and a beta of 5.66.

Karyopharm Therapeutics (KPTI)

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in the United States. The company discovers, develops, and commercializes novel and small molecule Selective Inhibitor of Nuclear Export (SINE) compounds that inhibit the nuclear export protein exportin 1 (XPO1).

NASDAQ:KPTI traded down $0.01 on Friday, hitting $0.05. The stock had a trading volume of 103,454,416 shares, compared to its average volume of 7,058,169. The stock has a market cap of $1.25 million, a price-to-earnings ratio of -0.00 and a beta of 1.16. The business’s 50-day simple moving average is $1.04 and its two-hundred day simple moving average is $5.85. Karyopharm Therapeutics has a 52-week low of $0.04 and a 52-week high of $10.99.